Analysts Set RXO, Inc. (NYSE:RXO) PT at $22.73

RXO, Inc. (NYSE:RXOGet Free Report) has been assigned an average recommendation of “Hold” from the seventeen brokerages that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $22.73.

RXO has been the topic of several research analyst reports. Oppenheimer cut shares of RXO from an “outperform” rating to a “market perform” rating in a report on Friday, April 4th. Truist Financial started coverage on RXO in a report on Thursday, March 13th. They issued a “buy” rating and a $24.00 price target on the stock. Jefferies Financial Group cut their price objective on RXO from $26.00 to $20.00 and set a “buy” rating for the company in a report on Friday, April 11th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of RXO in a research report on Friday, March 7th. They issued a “hold” rating and a $19.00 price objective on the stock. Finally, Barclays dropped their target price on shares of RXO from $24.00 to $22.00 and set an “overweight” rating for the company in a research report on Wednesday, April 2nd.

Get Our Latest Analysis on RXO

RXO Stock Up 2.3 %

RXO stock opened at $13.21 on Tuesday. RXO has a twelve month low of $12.39 and a twelve month high of $32.82. The firm has a market capitalization of $2.17 billion, a PE ratio of -6.23, a PEG ratio of 4.55 and a beta of 1.60. The company has a quick ratio of 1.33, a current ratio of 1.26 and a debt-to-equity ratio of 0.22. The stock has a 50-day simple moving average of $18.21 and a two-hundred day simple moving average of $23.92.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. On average, equities analysts predict that RXO will post 0.31 EPS for the current fiscal year.

Institutional Investors Weigh In On RXO

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in RXO by 13.2% in the 4th quarter. Vanguard Group Inc. now owns 17,203,721 shares of the company’s stock worth $410,137,000 after purchasing an additional 2,009,937 shares during the period. FIL Ltd grew its holdings in shares of RXO by 10.4% in the fourth quarter. FIL Ltd now owns 6,327,889 shares of the company’s stock worth $150,857,000 after purchasing an additional 596,158 shares during the last quarter. Douglas Lane & Associates LLC raised its holdings in RXO by 34.3% during the 1st quarter. Douglas Lane & Associates LLC now owns 3,591,040 shares of the company’s stock valued at $68,589,000 after buying an additional 916,379 shares during the last quarter. Geode Capital Management LLC boosted its position in RXO by 10.1% during the 4th quarter. Geode Capital Management LLC now owns 3,362,721 shares of the company’s stock valued at $80,185,000 after buying an additional 307,492 shares during the period. Finally, Vaughan Nelson Investment Management L.P. boosted its position in RXO by 15.0% during the 1st quarter. Vaughan Nelson Investment Management L.P. now owns 2,730,665 shares of the company’s stock valued at $52,155,000 after buying an additional 355,255 shares during the period. Institutional investors own 92.73% of the company’s stock.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Further Reading

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.